Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (11-20 of 522) with videos related to

Pageof 53
Sort By:
Cardiovascular Drugs and Therapy|June 16, 2006
The clinical relevance of low-density-lipoproteins size modulation by statinsManfredi Rizzo, Kaspar Berneis
Southern Medical Journal|November 14, 2008
Recent insights on dark chocolate consumption and cardiovascular riskManfredi Rizzo, Kaspar Berneis
International Journal of Cardiology|January 18, 2006
Should we measure routinely the LDL peak particle size?Manfredi Rizzo, Kaspar Berneis
Current Pharmaceutical Design|February 15, 2026
Reshaping the Future of MASLD - From Pathophysiological Mechanisms to New Therapeutic HorizonsDimitrios Patoulias, Manfredi Rizzo
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
A Potential Link between Serum Low-Density Lipoproteins and AsthmaNicola Scichilone, Manfredi Rizzo
European Journal of Internal Medicine|February 24, 2006
Low-density lipoprotein size and cardiovascular preventionManfredi Rizzo, Kaspar Berneis
Diabetes/Metabolism Research and Reviews|November 3, 2006
Small, dense low-density-lipoproteins and the metabolic syndromeManfredi Rizzo, Kaspar Berneis
Current Vascular Pharmacology|December 22, 2012
Can statins mitigate the adverse cardiovascular effects of smoking?Ioanna Gouni-Berthold, Manfredi Rizzo
Archives of Medical Science : AMS|February 1, 2012
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemiaManfredi Rizzo, Giovam Battista Rini
International Journal of Molecular Sciences|August 10, 2024
New Advances in Metabolic SyndromeManfredi Rizzo, Ali A Rizvi
Pageof 53

Showing results (11-20 of 522) with videos related to

Sort By:
Pageof 53
Cardiovascular Drugs and Therapy|June 16, 2006
The clinical relevance of low-density-lipoproteins size modulation by statinsManfredi Rizzo, Kaspar Berneis
Southern Medical Journal|November 14, 2008
Recent insights on dark chocolate consumption and cardiovascular riskManfredi Rizzo, Kaspar Berneis
International Journal of Cardiology|January 18, 2006
Should we measure routinely the LDL peak particle size?Manfredi Rizzo, Kaspar Berneis
Current Pharmaceutical Design|February 15, 2026
Reshaping the Future of MASLD - From Pathophysiological Mechanisms to New Therapeutic HorizonsDimitrios Patoulias, Manfredi Rizzo
American Journal of Respiratory and Critical Care Medicine|July 16, 2015
A Potential Link between Serum Low-Density Lipoproteins and AsthmaNicola Scichilone, Manfredi Rizzo
European Journal of Internal Medicine|February 24, 2006
Low-density lipoprotein size and cardiovascular preventionManfredi Rizzo, Kaspar Berneis
Diabetes/Metabolism Research and Reviews|November 3, 2006
Small, dense low-density-lipoproteins and the metabolic syndromeManfredi Rizzo, Kaspar Berneis
Current Vascular Pharmacology|December 22, 2012
Can statins mitigate the adverse cardiovascular effects of smoking?Ioanna Gouni-Berthold, Manfredi Rizzo
Archives of Medical Science : AMS|February 1, 2012
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemiaManfredi Rizzo, Giovam Battista Rini
International Journal of Molecular Sciences|August 10, 2024
New Advances in Metabolic SyndromeManfredi Rizzo, Ali A Rizvi
Pageof 53